Understanding Ocular Migraine: A Comprehensive Overview
Ocular migraine, also known as retinal migraine or visual migraine, is a neurological condition characterized by temporary visual disturbances. These disturbances often manifest as flickering lights, zigzag lines, blind spots, or shimmering or wavy vision. Unlike typical migraines, ocular migraines primarily affect the vision without necessarily causing severe headache pain. There are two main types of ocular migraines: migraine with aura and migraine without aura.
Types of Ocular Migraine:
Migraine with Aura: This type of ocular migraine is characterized by visual disturbances, known as aura, that precede or accompany the headache phase. Aura symptoms may include flashing lights, blind spots, zigzag lines, or other visual distortions. These symptoms typically last for about 20 to 30 minutes and are followed by a headache, although some individuals may not experience a headache at all.
Migraine without Aura: In this type of ocular migraine, visual disturbances occur without the presence of aura or significant headache pain. Individuals may experience temporary vision loss, blind spots, or other visual disturbances that resolve on their own within an hour. While the visual symptoms can be alarming, they are usually harmless and do not cause permanent vision loss.
Diagnosis and Management:
Diagnosing ocular migraine involves ruling out other potential causes of visual disturbances, such as retinal detachment or transient ischemic attack (TIA). A thorough medical history, including a history of migraine headaches, and a comprehensive eye examination are typically conducted. Imaging tests such as MRI or CT scans may be recommended to rule out other underlying conditions.
Treatment with Retyne Infrared Eye Treatment Mask:
The Retyne Infrared Eye Treatment Mask offers a promising approach to managing the symptoms of ocular migraine, particularly through Program #2 on the Retyne controller. This program utilizes invisible infrared light therapy to promote relaxation, reduce inflammation, and improve blood circulation in the eye tissues. By targeting the underlying mechanisms that contribute to ocular migraine, such as vascular dysfunction and neuronal hyperexcitability, the Retyne mask can help alleviate visual disturbances and prevent future episodes.
Ocular migraine is a unique neurological condition characterized by temporary visual disturbances that can significantly impact daily life. While there is no cure for ocular migraine, effective management strategies such as the use of the Retyne Infrared Eye Treatment Mask can help reduce the frequency and severity of symptoms. With its innovative approach to infrared light therapy, the Retyne mask offers new hope for individuals seeking relief from ocular migraine and its associated visual disturbances.
The Retyne eye treatment mask utilizes a general selection of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5) tailored to address Ocular Migraine. These frequencies have been selected for their proven effectiveness in managing and treating this visual condition.
Retyne's approach involves converting each frequency into invisible infrared light output, marking a groundbreaking fusion of frequencies with light—a pioneering technology pioneered by Retyne Labs. Inspired by the groundbreaking work of Dr. Rife, who identified healing properties in specific frequencies and utilized light for their transmission, Retyne's innovative method capitalizes on current research on invisible infrared technology and builds upon past studies on light transmission through frequency sources. The result is the Retyne eye Treatment Mask, a convergence of state-of-the-art advancements in the field of visual care.
Moreover, for those utilizing advanced hardware such as the RDPV4, a secondary set of specific frequencies for Ocular Migraine (2165: Migraine Disorders: 0.1, 0.52, 7.5, 30.23, 226.5, 430.15, 527, 662.8, 749, 986.22 ) is available. The RDPV4 offers an expanded range of frequencies, finely calibrated to provide even greater precision for the treatment of this Corneal Disorder. By incorporating this secondary set of frequencies, the RDPV4 elevates the potential therapeutic benefits of the Retyne eye Treatment Mask, catering to individuals seeking advanced solutions for their visual health needs.
The general group: 1407: 0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5
The specific group: 2165: Migraine Disorders: 0.1, 0.52, 7.5, 30.23, 226.5, 430.15, 527, 662.8, 749, 986.22
Ocular Migraine General Group exists at program 1233 on the International ETDFL frequency list
Compatibility
Standalone controller (Program #2) (Controller shipped with Retyne Eye Treatment Mask)
RDPV4 (Direct connect, use group 2165)
RDPV4 Light Mask Program button 2
Click here for instructions on using the Retyne Mask + Controller
